Fig. 4From: Comparison of treatment effect sizes from pivotal and postapproval trials of novel therapeutics approved by the FDA based on surrogate markers of disease: a meta-epidemiological studyIndividual and summary standardized mean differences from pivotal and postapproval trials fulfilling at least two matching criteria and reporting continuous endpointsBack to article page